This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Shunichiro Uesugi: Innovator in Pharmaceutical Chemistry
Introduction
Shunichiro Uesugi is a notable inventor based in Osaka-shi, Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work at Sumitomo Pharma Co., Ltd. His expertise and dedication have led to the development of valuable patents that enhance the pharmaceutical landscape.
Latest Patents
Uesugi holds a patent for "Tertiary Amide Derivatives Substituted with 4-Membered Ring Structure." This invention showcases his ability to create novel compounds that may have important applications in drug development. He has 1 patent to his name, reflecting his innovative contributions to the industry.
Career Highlights
Throughout his career, Uesugi has demonstrated a commitment to advancing pharmaceutical research. His work at Sumitomo Pharma Co., Ltd. has positioned him as a key player in the development of new therapeutic agents. His innovative spirit and technical skills have earned him recognition in the field.
Collaborations
Uesugi collaborates with talented professionals, including his coworker Yusuke Kamei. Together, they contribute to the innovative projects at Sumitomo Pharma Co., Ltd., fostering a collaborative environment that encourages creativity and scientific advancement.
Conclusion
Shunichiro Uesugi is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact. His patent for tertiary amide derivatives exemplifies his innovative approach to drug development. Uesugi's contributions continue to shape the future of pharmaceuticals, highlighting the importance of innovation in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile